BIOMAT Database Logo BIOMAT Database Logo

Metformin [Glucophage]: new treatment for NIDDM. 1995

B Bihm, and B A Wilson

UI MeSH Term Description Entries
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D010353 Patient Education as Topic The teaching or training of patients concerning their own health needs. Education of Patients,Education, Patient,Patient Education
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Bihm, and B A Wilson
Glucophage (metformin hydrochloride).
January 1996, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates,
B Bihm, and B A Wilson
Cranial CT findings in metformin (Glucophage)-induced lactic acidosis.
January 1998, Journal of computer assisted tomography,
B Bihm, and B A Wilson
Metformin as an adjunctive therapy for NIDDM.
April 1996, The Nurse practitioner,
B Bihm, and B A Wilson
Metformin treatment in NIDDM patients with mild renal impairment.
June 1996, Postgraduate medical journal,
B Bihm, and B A Wilson
Efficacy of metformin in the treatment of NIDDM. Meta-analysis.
January 1999, Diabetes care,
B Bihm, and B A Wilson
New therapeutic agents for the treatment of NIDDM.
January 1996, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
B Bihm, and B A Wilson
Metformin: a safe and effective treatment in the management of NIDDM.
March 1997, Missouri medicine,
B Bihm, and B A Wilson
[Report on 5-years' experience with dimethylbiguanide (metformin, glucophage) in diabetic therapy].
August 1963, Wiener medizinische Wochenschrift (1946),
B Bihm, and B A Wilson
Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase.
June 2004, Biochemical pharmacology,
B Bihm, and B A Wilson
Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus.
January 2021, Frontiers in endocrinology,
Copied contents to your clipboard!